Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis | 49 | 2024 | 1862 | 4.540 |
Why?
|
Bariatric Surgery | 9 | 2021 | 952 | 1.560 |
Why?
|
Fatty Liver | 9 | 2024 | 727 | 1.500 |
Why?
|
Liver | 40 | 2024 | 7475 | 1.460 |
Why?
|
Elasticity Imaging Techniques | 8 | 2023 | 388 | 1.340 |
Why?
|
Hepatitis C | 11 | 2022 | 1591 | 1.250 |
Why?
|
Thiazolidinediones | 4 | 2021 | 476 | 1.190 |
Why?
|
Cardiovascular Diseases | 16 | 2022 | 15160 | 1.140 |
Why?
|
Dyslipidemias | 5 | 2019 | 849 | 1.130 |
Why?
|
End Stage Liver Disease | 5 | 2024 | 314 | 1.020 |
Why?
|
Hepatitis C, Chronic | 10 | 2020 | 1031 | 1.010 |
Why?
|
Carcinoma, Hepatocellular | 16 | 2024 | 2214 | 0.980 |
Why?
|
Vitamin E | 3 | 2019 | 869 | 0.950 |
Why?
|
Lipoproteins | 2 | 2019 | 878 | 0.810 |
Why?
|
Obesity, Morbid | 7 | 2021 | 1213 | 0.790 |
Why?
|
Liver Neoplasms | 16 | 2024 | 4253 | 0.770 |
Why?
|
HIV Infections | 15 | 2023 | 16715 | 0.730 |
Why?
|
Antiviral Agents | 9 | 2020 | 2987 | 0.720 |
Why?
|
Growth Hormone-Releasing Hormone | 5 | 2021 | 213 | 0.720 |
Why?
|
Gastroenterology | 4 | 2020 | 538 | 0.700 |
Why?
|
Disease Susceptibility | 4 | 2023 | 1782 | 0.680 |
Why?
|
Obesity | 18 | 2023 | 12746 | 0.640 |
Why?
|
Hepacivirus | 11 | 2020 | 1379 | 0.630 |
Why?
|
Liver Diseases | 3 | 2018 | 1253 | 0.620 |
Why?
|
Aspirin | 5 | 2024 | 3283 | 0.620 |
Why?
|
Thinness | 1 | 2021 | 480 | 0.620 |
Why?
|
Weight Loss | 9 | 2020 | 2625 | 0.610 |
Why?
|
Biopsy | 16 | 2022 | 6755 | 0.600 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2015 | 1813 | 0.580 |
Why?
|
Aspartate Aminotransferases | 4 | 2019 | 418 | 0.520 |
Why?
|
Risk Factors | 37 | 2022 | 72296 | 0.510 |
Why?
|
Middle Aged | 71 | 2024 | 213390 | 0.510 |
Why?
|
Fibrosis | 10 | 2023 | 2029 | 0.490 |
Why?
|
Humans | 138 | 2024 | 744366 | 0.480 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2023 | 11726 | 0.480 |
Why?
|
Lipids | 5 | 2022 | 3307 | 0.480 |
Why?
|
Esophageal Neoplasms | 3 | 2019 | 1585 | 0.470 |
Why?
|
Rhizopus | 1 | 2013 | 21 | 0.470 |
Why?
|
Alanine Transaminase | 5 | 2021 | 592 | 0.470 |
Why?
|
Adult | 61 | 2024 | 214052 | 0.470 |
Why?
|
Disease Progression | 17 | 2023 | 13286 | 0.440 |
Why?
|
Hepatitis, Autoimmune | 2 | 2014 | 141 | 0.440 |
Why?
|
International Cooperation | 1 | 2019 | 1420 | 0.430 |
Why?
|
Male | 81 | 2024 | 350115 | 0.430 |
Why?
|
Mucormycosis | 1 | 2013 | 97 | 0.430 |
Why?
|
Stomach Diseases | 1 | 2013 | 134 | 0.420 |
Why?
|
Diabetes Mellitus | 6 | 2023 | 5749 | 0.420 |
Why?
|
Overweight | 3 | 2023 | 2371 | 0.410 |
Why?
|
Interferon-alpha | 4 | 2015 | 895 | 0.410 |
Why?
|
Female | 81 | 2024 | 380193 | 0.410 |
Why?
|
Body Mass Index | 11 | 2021 | 12721 | 0.400 |
Why?
|
Gene Expression | 2 | 2021 | 7798 | 0.390 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 941 | 0.390 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 537 | 0.390 |
Why?
|
Cholesterol, LDL | 5 | 2014 | 2355 | 0.380 |
Why?
|
Sports Medicine | 2 | 2023 | 225 | 0.380 |
Why?
|
Polyethylene Glycols | 4 | 2015 | 1182 | 0.370 |
Why?
|
Deglutition Disorders | 1 | 2016 | 606 | 0.370 |
Why?
|
Cohort Studies | 18 | 2022 | 40559 | 0.360 |
Why?
|
Ventricular Remodeling | 1 | 2017 | 1223 | 0.350 |
Why?
|
Losartan | 1 | 2011 | 299 | 0.350 |
Why?
|
Incidental Findings | 1 | 2014 | 689 | 0.340 |
Why?
|
Thiolester Hydrolases | 2 | 2020 | 86 | 0.340 |
Why?
|
Cost-Benefit Analysis | 6 | 2019 | 5388 | 0.340 |
Why?
|
Stomach | 1 | 2013 | 697 | 0.330 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2009 | 102 | 0.330 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2760 | 0.330 |
Why?
|
Triglycerides | 5 | 2019 | 2453 | 0.320 |
Why?
|
Fatty Acids | 3 | 2021 | 1809 | 0.310 |
Why?
|
Hypoglycemic Agents | 2 | 2021 | 2873 | 0.310 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6486 | 0.300 |
Why?
|
Natural Language Processing | 1 | 2015 | 1041 | 0.300 |
Why?
|
Disease Management | 1 | 2018 | 2460 | 0.300 |
Why?
|
Prevalence | 10 | 2023 | 15221 | 0.290 |
Why?
|
Developing Countries | 1 | 2019 | 2815 | 0.290 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 253 | 0.280 |
Why?
|
HIV | 7 | 2023 | 1604 | 0.280 |
Why?
|
Clinical Laboratory Techniques | 1 | 2012 | 738 | 0.280 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 3070 | 0.280 |
Why?
|
Data Mining | 2 | 2021 | 537 | 0.270 |
Why?
|
Macrophage Activation | 2 | 2019 | 560 | 0.270 |
Why?
|
Electronic Health Records | 3 | 2020 | 4468 | 0.260 |
Why?
|
Prospective Studies | 15 | 2022 | 53290 | 0.260 |
Why?
|
Risk Reduction Behavior | 3 | 2020 | 1125 | 0.260 |
Why?
|
Cross-Sectional Studies | 12 | 2023 | 25039 | 0.260 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2023 | 2917 | 0.250 |
Why?
|
Heart | 2 | 2017 | 4464 | 0.250 |
Why?
|
Alcohol Drinking | 2 | 2020 | 3966 | 0.250 |
Why?
|
Aged | 35 | 2024 | 163288 | 0.250 |
Why?
|
Logistic Models | 6 | 2021 | 13409 | 0.250 |
Why?
|
Gastric Bypass | 4 | 2018 | 812 | 0.240 |
Why?
|
Metformin | 1 | 2011 | 836 | 0.240 |
Why?
|
Lipoproteins, HDL | 3 | 2014 | 638 | 0.240 |
Why?
|
Algorithms | 4 | 2020 | 13882 | 0.240 |
Why?
|
Myocardial Infarction | 3 | 2020 | 11718 | 0.240 |
Why?
|
Hepatitis | 2 | 2023 | 227 | 0.230 |
Why?
|
Glucokinase | 1 | 2023 | 103 | 0.230 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2023 | 2016 | 0.230 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15078 | 0.230 |
Why?
|
Uganda | 2 | 2019 | 1237 | 0.220 |
Why?
|
Fundoplication | 1 | 2003 | 138 | 0.220 |
Why?
|
Ultrasonography | 1 | 2016 | 5984 | 0.220 |
Why?
|
Liver Transplantation | 4 | 2019 | 2119 | 0.210 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1516 | 0.210 |
Why?
|
Hepatitis, Alcoholic | 1 | 2023 | 103 | 0.200 |
Why?
|
Remission Induction | 2 | 2019 | 2385 | 0.200 |
Why?
|
Common Variable Immunodeficiency | 1 | 2022 | 93 | 0.200 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2023 | 161 | 0.190 |
Why?
|
RNA, Viral | 6 | 2015 | 2901 | 0.190 |
Why?
|
Severity of Illness Index | 11 | 2023 | 15535 | 0.190 |
Why?
|
Acyl Coenzyme A | 1 | 2020 | 55 | 0.190 |
Why?
|
Somatotypes | 1 | 2020 | 42 | 0.190 |
Why?
|
Massachusetts | 3 | 2021 | 8662 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4034 | 0.190 |
Why?
|
Models, Biological | 2 | 2021 | 9584 | 0.190 |
Why?
|
Ribavirin | 3 | 2015 | 395 | 0.180 |
Why?
|
ROC Curve | 2 | 2021 | 3528 | 0.180 |
Why?
|
Anticholesteremic Agents | 2 | 2018 | 979 | 0.180 |
Why?
|
Hypertension, Portal | 1 | 2022 | 220 | 0.180 |
Why?
|
United States | 18 | 2023 | 69872 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 216 | 0.180 |
Why?
|
Case-Control Studies | 6 | 2021 | 21748 | 0.170 |
Why?
|
Double-Blind Method | 8 | 2024 | 12025 | 0.170 |
Why?
|
Lipoproteins, LDL | 2 | 2014 | 640 | 0.170 |
Why?
|
Barrett Esophagus | 1 | 2003 | 494 | 0.170 |
Why?
|
Smoking | 1 | 2016 | 8987 | 0.170 |
Why?
|
Biomass | 1 | 2019 | 125 | 0.170 |
Why?
|
Retrospective Studies | 16 | 2023 | 77460 | 0.170 |
Why?
|
Growth Substances | 1 | 2021 | 784 | 0.170 |
Why?
|
Lipogenesis | 1 | 2020 | 212 | 0.160 |
Why?
|
Heating | 1 | 2019 | 97 | 0.160 |
Why?
|
Eicosanoids | 1 | 2020 | 279 | 0.160 |
Why?
|
Weight Gain | 2 | 2020 | 2293 | 0.160 |
Why?
|
Public-Private Sector Partnerships | 1 | 2019 | 121 | 0.160 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2019 | 188 | 0.160 |
Why?
|
Lipoproteins, VLDL | 1 | 2019 | 201 | 0.160 |
Why?
|
Pentanoic Acids | 1 | 2017 | 15 | 0.160 |
Why?
|
Vitamin D | 1 | 2012 | 3224 | 0.160 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 697 | 0.160 |
Why?
|
Community-Institutional Relations | 1 | 2019 | 204 | 0.150 |
Why?
|
Adrenal Insufficiency | 1 | 2019 | 184 | 0.150 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12356 | 0.150 |
Why?
|
Liver Function Tests | 2 | 2021 | 528 | 0.150 |
Why?
|
Hepatocytes | 3 | 2021 | 1211 | 0.150 |
Why?
|
Stroke | 1 | 2020 | 9981 | 0.150 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39052 | 0.150 |
Why?
|
Area Under Curve | 1 | 2021 | 1655 | 0.150 |
Why?
|
Exercise | 5 | 2023 | 5615 | 0.150 |
Why?
|
Chenodeoxycholic Acid | 1 | 2017 | 34 | 0.150 |
Why?
|
Human Growth Hormone | 1 | 2022 | 683 | 0.150 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 294 | 0.150 |
Why?
|
Sports | 1 | 2023 | 688 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2023 | 658 | 0.150 |
Why?
|
Cooking | 1 | 2019 | 313 | 0.140 |
Why?
|
Guanidines | 1 | 2017 | 193 | 0.140 |
Why?
|
Kenya | 1 | 2019 | 685 | 0.140 |
Why?
|
E-Selectin | 1 | 2019 | 579 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2003 | 975 | 0.140 |
Why?
|
Organ Specificity | 1 | 2021 | 2008 | 0.140 |
Why?
|
Platelet Count | 1 | 2019 | 780 | 0.140 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 707 | 0.140 |
Why?
|
Program Development | 2 | 2020 | 1316 | 0.140 |
Why?
|
Pyruvate Kinase | 1 | 2018 | 189 | 0.140 |
Why?
|
Treatment Outcome | 12 | 2019 | 63107 | 0.140 |
Why?
|
Blood Proteins | 1 | 2021 | 1124 | 0.140 |
Why?
|
Pentoxifylline | 1 | 2016 | 55 | 0.140 |
Why?
|
Cholangitis | 1 | 2017 | 108 | 0.140 |
Why?
|
Health Personnel | 1 | 2009 | 3219 | 0.140 |
Why?
|
Jejunum | 1 | 2018 | 480 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2016 | 2916 | 0.130 |
Why?
|
Incidence | 6 | 2021 | 20952 | 0.130 |
Why?
|
Up-Regulation | 2 | 2023 | 4222 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20130 | 0.130 |
Why?
|
Lipid Metabolism | 3 | 2020 | 1889 | 0.130 |
Why?
|
Thyroid Hormones | 1 | 2018 | 390 | 0.130 |
Why?
|
Carrier Proteins | 2 | 2019 | 5023 | 0.130 |
Why?
|
Trientine | 1 | 2014 | 11 | 0.130 |
Why?
|
Comorbidity | 6 | 2022 | 10388 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 719 | 0.130 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2019 | 1159 | 0.130 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2020 | 838 | 0.130 |
Why?
|
Diastole | 1 | 2017 | 791 | 0.130 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 14723 | 0.120 |
Why?
|
Particle Size | 1 | 2019 | 1642 | 0.120 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2016 | 227 | 0.120 |
Why?
|
Hepatolenticular Degeneration | 1 | 2014 | 69 | 0.120 |
Why?
|
Remission, Spontaneous | 1 | 2015 | 382 | 0.120 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3255 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1790 | 0.120 |
Why?
|
Program Evaluation | 2 | 2020 | 2488 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2560 | 0.120 |
Why?
|
Gene Expression Regulation | 4 | 2021 | 12073 | 0.120 |
Why?
|
Melena | 1 | 2013 | 34 | 0.120 |
Why?
|
Attitude | 1 | 2019 | 776 | 0.120 |
Why?
|
Palliative Care | 2 | 2019 | 3493 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2021 | 13991 | 0.120 |
Why?
|
Down-Regulation | 1 | 2021 | 3001 | 0.120 |
Why?
|
Lipase | 1 | 2016 | 314 | 0.120 |
Why?
|
Adolescent | 12 | 2024 | 85779 | 0.120 |
Why?
|
Peroxidase | 1 | 2017 | 611 | 0.120 |
Why?
|
Forecasting | 2 | 2020 | 2951 | 0.110 |
Why?
|
Stomach Ulcer | 1 | 2013 | 125 | 0.110 |
Why?
|
Coronary Angiography | 2 | 2022 | 4576 | 0.110 |
Why?
|
Adiposity | 2 | 2021 | 1806 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 573 | 0.110 |
Why?
|
Health Care Costs | 2 | 2017 | 3208 | 0.110 |
Why?
|
Heart Failure | 1 | 2017 | 10895 | 0.110 |
Why?
|
Transaminases | 1 | 2014 | 200 | 0.110 |
Why?
|
Anti-Obesity Agents | 1 | 2016 | 217 | 0.110 |
Why?
|
Cholesterol | 2 | 2014 | 2919 | 0.110 |
Why?
|
Epidermal Growth Factor | 1 | 2016 | 709 | 0.110 |
Why?
|
Anorexia | 1 | 2013 | 161 | 0.110 |
Why?
|
Chelating Agents | 1 | 2014 | 380 | 0.110 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12961 | 0.110 |
Why?
|
Cecum | 1 | 2013 | 237 | 0.110 |
Why?
|
Blood Glucose | 2 | 2021 | 6254 | 0.110 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11366 | 0.110 |
Why?
|
Desmosterol | 1 | 2012 | 3 | 0.110 |
Why?
|
Young Adult | 13 | 2024 | 56429 | 0.110 |
Why?
|
Markov Chains | 1 | 2016 | 969 | 0.110 |
Why?
|
Estrogens | 1 | 2019 | 1566 | 0.110 |
Why?
|
Computational Biology | 2 | 2021 | 3519 | 0.100 |
Why?
|
Air Pollution, Indoor | 1 | 2019 | 857 | 0.100 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1504 | 0.100 |
Why?
|
Creatinine | 1 | 2017 | 1919 | 0.100 |
Why?
|
Advance Care Planning | 1 | 2019 | 662 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2018 | 1530 | 0.100 |
Why?
|
Hydrocortisone | 1 | 2019 | 1826 | 0.100 |
Why?
|
Insulin Resistance | 2 | 2016 | 3864 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3638 | 0.100 |
Why?
|
Recombinant Proteins | 3 | 2009 | 6621 | 0.100 |
Why?
|
Interleukins | 1 | 2016 | 791 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1579 | 0.100 |
Why?
|
Quality-Adjusted Life Years | 4 | 2019 | 1683 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2016 | 1184 | 0.090 |
Why?
|
International Classification of Diseases | 1 | 2015 | 867 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2016 | 868 | 0.090 |
Why?
|
Amantadine | 1 | 2009 | 55 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2018 | 7882 | 0.090 |
Why?
|
Radiology Information Systems | 1 | 2014 | 523 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2017 | 828 | 0.090 |
Why?
|
Blood-Borne Pathogens | 1 | 2009 | 52 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 1999 | 2162 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12244 | 0.090 |
Why?
|
Life Style | 2 | 2021 | 3835 | 0.090 |
Why?
|
Growth Hormone | 2 | 2023 | 705 | 0.090 |
Why?
|
Adipose Tissue | 2 | 2021 | 3280 | 0.090 |
Why?
|
Needlestick Injuries | 1 | 2009 | 67 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3595 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2865 | 0.080 |
Why?
|
Medical Records | 1 | 2014 | 1413 | 0.080 |
Why?
|
Hypertension | 1 | 2009 | 8479 | 0.080 |
Why?
|
Virus Activation | 1 | 2010 | 319 | 0.080 |
Why?
|
Odds Ratio | 2 | 2023 | 9849 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9445 | 0.080 |
Why?
|
Prognosis | 6 | 2020 | 29060 | 0.080 |
Why?
|
Immunocompromised Host | 1 | 2013 | 847 | 0.080 |
Why?
|
Documentation | 1 | 2014 | 871 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3203 | 0.080 |
Why?
|
Acute Disease | 2 | 2011 | 7147 | 0.080 |
Why?
|
Macrophages | 2 | 2019 | 5660 | 0.080 |
Why?
|
Antioxidants | 1 | 2016 | 1659 | 0.080 |
Why?
|
Epidemics | 1 | 2014 | 523 | 0.080 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.080 |
Why?
|
History, 21st Century | 1 | 2014 | 1534 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2014 | 814 | 0.080 |
Why?
|
Heart Diseases | 1 | 2020 | 2789 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4386 | 0.080 |
Why?
|
Diarrhea | 1 | 2014 | 1348 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12262 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 693 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1707 | 0.070 |
Why?
|
Hepatitis B virus | 1 | 2010 | 513 | 0.070 |
Why?
|
Abdominal Pain | 1 | 2013 | 1064 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2015 | 2441 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2670 | 0.070 |
Why?
|
Risk Assessment | 6 | 2020 | 23336 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8642 | 0.070 |
Why?
|
Placebos | 2 | 2021 | 1676 | 0.070 |
Why?
|
Data Collection | 1 | 2015 | 3339 | 0.070 |
Why?
|
Risk | 2 | 2017 | 9688 | 0.070 |
Why?
|
Hepatitis B, Chronic | 1 | 2010 | 393 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2003 | 6364 | 0.070 |
Why?
|
Mice | 10 | 2023 | 81201 | 0.070 |
Why?
|
Genotype | 5 | 2016 | 12952 | 0.070 |
Why?
|
Viral Load | 3 | 2015 | 3300 | 0.070 |
Why?
|
Patient Admission | 1 | 2013 | 1380 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2019 | 3531 | 0.070 |
Why?
|
Obesity, Abdominal | 2 | 2021 | 361 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3229 | 0.070 |
Why?
|
Electrocardiography | 1 | 1999 | 6442 | 0.070 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18034 | 0.070 |
Why?
|
Genetic Variation | 1 | 2020 | 6542 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3666 | 0.060 |
Why?
|
Echocardiography | 1 | 2017 | 5099 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1813 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2022 | 19905 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3326 | 0.060 |
Why?
|
Inflammation | 3 | 2023 | 10637 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 2 | 2020 | 1157 | 0.060 |
Why?
|
Intra-Abdominal Fat | 2 | 2021 | 591 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2020 | 57776 | 0.060 |
Why?
|
Quality of Life | 5 | 2023 | 12802 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.060 |
Why?
|
Time Factors | 6 | 2019 | 40075 | 0.060 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 1381 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2535 | 0.050 |
Why?
|
Primary Health Care | 2 | 2020 | 4557 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Animals | 11 | 2023 | 168768 | 0.050 |
Why?
|
Atherosclerosis | 2 | 2016 | 3444 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8551 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3778 | 0.050 |
Why?
|
Diacylglycerol O-Acyltransferase | 1 | 2020 | 22 | 0.050 |
Why?
|
Chronic Disease | 4 | 2019 | 9145 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2023 | 472 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 7730 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.050 |
Why?
|
PPAR alpha | 1 | 2021 | 197 | 0.050 |
Why?
|
Pilot Projects | 2 | 2013 | 8319 | 0.050 |
Why?
|
Pituitary-Adrenal Function Tests | 1 | 2019 | 31 | 0.050 |
Why?
|
Physicians | 1 | 2018 | 4567 | 0.040 |
Why?
|
Glucose | 2 | 2023 | 4398 | 0.040 |
Why?
|
Globulins | 1 | 2019 | 19 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2022 | 390 | 0.040 |
Why?
|
Smad Proteins | 1 | 2020 | 162 | 0.040 |
Why?
|
Sulfonylurea Compounds | 1 | 2021 | 205 | 0.040 |
Why?
|
DNA, Viral | 1 | 2006 | 2227 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3751 | 0.040 |
Why?
|
Nurses | 2 | 2020 | 2462 | 0.040 |
Why?
|
Charcoal | 1 | 2019 | 62 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 15520 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 249 | 0.040 |
Why?
|
Occupational Exposure | 1 | 2009 | 1793 | 0.040 |
Why?
|
Coal | 1 | 2019 | 119 | 0.040 |
Why?
|
Wood | 1 | 2019 | 89 | 0.040 |
Why?
|
Streptokinase | 1 | 1999 | 188 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1185 | 0.040 |
Why?
|
Mass Screening | 2 | 2011 | 5253 | 0.040 |
Why?
|
Tissue Donors | 2 | 2020 | 2241 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 481 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5791 | 0.040 |
Why?
|
Myocardial Reperfusion | 1 | 1999 | 351 | 0.040 |
Why?
|
Diet Surveys | 1 | 2021 | 1173 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21833 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 878 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2021 | 644 | 0.040 |
Why?
|
Signal Transduction | 1 | 2020 | 23404 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 1014 | 0.040 |
Why?
|
Ethanol | 1 | 2023 | 1342 | 0.040 |
Why?
|
Shear Strength | 1 | 2017 | 165 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1572 | 0.040 |
Why?
|
Gastroesophageal Reflux | 1 | 2003 | 782 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2017 | 214 | 0.030 |
Why?
|
Trans-Activators | 2 | 2016 | 2926 | 0.030 |
Why?
|
Hepatic Stellate Cells | 1 | 2016 | 109 | 0.030 |
Why?
|
Coronary Disease | 1 | 2011 | 6077 | 0.030 |
Why?
|
Cultural Competency | 1 | 2019 | 289 | 0.030 |
Why?
|
Waist Circumference | 1 | 2020 | 917 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9274 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 976 | 0.030 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2015 | 115 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1379 | 0.030 |
Why?
|
Transcription Factors | 3 | 2023 | 12207 | 0.030 |
Why?
|
Time | 1 | 2017 | 542 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14561 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2020 | 865 | 0.030 |
Why?
|
Benzylamines | 1 | 2015 | 223 | 0.030 |
Why?
|
Waiting Lists | 1 | 2019 | 692 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2021 | 1206 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1147 | 0.030 |
Why?
|
Benzoates | 1 | 2015 | 217 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 745 | 0.030 |
Why?
|
Thrombophilia | 1 | 2016 | 305 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1107 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2017 | 1799 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2020 | 904 | 0.030 |
Why?
|
Spine | 1 | 2021 | 1144 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15297 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2017 | 836 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2504 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9955 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1195 | 0.030 |
Why?
|
Feces | 1 | 2019 | 1401 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 4982 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2017 | 492 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6489 | 0.030 |
Why?
|
Internationality | 1 | 2018 | 1002 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2751 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 1999 | 1261 | 0.030 |
Why?
|
Drug Discovery | 1 | 2020 | 1058 | 0.030 |
Why?
|
Interferons | 1 | 2016 | 706 | 0.030 |
Why?
|
Career Choice | 1 | 2018 | 744 | 0.030 |
Why?
|
Gastrectomy | 1 | 2016 | 663 | 0.030 |
Why?
|
Copper | 1 | 2014 | 366 | 0.030 |
Why?
|
Marital Status | 1 | 2013 | 437 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 783 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2017 | 1686 | 0.030 |
Why?
|
Administration, Oral | 1 | 2019 | 3914 | 0.030 |
Why?
|
Nausea | 1 | 2014 | 674 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1641 | 0.020 |
Why?
|
Pulmonary Fibrosis | 1 | 2015 | 530 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2020 | 1418 | 0.020 |
Why?
|
Child | 2 | 2020 | 77709 | 0.020 |
Why?
|
Diet | 2 | 2021 | 7937 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1707 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2021 | 2050 | 0.020 |
Why?
|
Hepatitis Antibodies | 1 | 2010 | 73 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1781 | 0.020 |
Why?
|
New England | 1 | 2013 | 1022 | 0.020 |
Why?
|
Diuretics | 1 | 2013 | 591 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3511 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2015 | 1438 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1539 | 0.020 |
Why?
|
Postoperative Care | 1 | 2016 | 1487 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 1972 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35425 | 0.020 |
Why?
|
Hepatitis C Antibodies | 1 | 2009 | 145 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2688 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4410 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2021 | 3188 | 0.020 |
Why?
|
Viral Envelope Proteins | 1 | 2013 | 636 | 0.020 |
Why?
|
Models, Economic | 1 | 2013 | 712 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17446 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3743 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4933 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3611 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
Serologic Tests | 1 | 2010 | 374 | 0.020 |
Why?
|
Pyrimidines | 1 | 2020 | 2943 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1741 | 0.020 |
Why?
|
Bone Density | 1 | 2021 | 3468 | 0.020 |
Why?
|
Mexico | 1 | 2009 | 689 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2016 | 4777 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13693 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5101 | 0.020 |
Why?
|
Myocardium | 1 | 1999 | 4772 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3084 | 0.020 |
Why?
|
Graft Survival | 1 | 2016 | 3737 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 16000 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12797 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3841 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2015 | 1534 | 0.020 |
Why?
|
Communication | 1 | 2019 | 3750 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5984 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10400 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4459 | 0.010 |
Why?
|
Virus Replication | 1 | 2012 | 2535 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6539 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18373 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5300 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16690 | 0.010 |
Why?
|
Rats | 1 | 2019 | 24252 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16367 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4397 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2616 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5321 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7914 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 19233 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7282 | 0.010 |
Why?
|
Gamma Rays | 1 | 1960 | 320 | 0.000 |
Why?
|
Equipment and Supplies | 1 | 1960 | 281 | 0.000 |
Why?
|
Radiometry | 1 | 1960 | 800 | 0.000 |
Why?
|